Mapping the surface of pancreatic cancer cells

Identifying proteins on pancreatic cancer cells that could become new targets for developing future treatments.
Picture: Professor Tracy Putoczki, Laboratory Head at WEHI

Mapping the surface of pancreatic cancer cells

July 1, 2026
Identifying proteins on pancreatic cancer cells that could become new targets for developing future treatments.
Read Transcript

The challenge 

Pancreatic cancer remains one of the deadliest cancers in Australia. It is the third most common cause of cancer-related death, with an incidence rate of 14 cases per 100,000 people. It is particularly difficult to treat because it is often diagnosed at an advanced stage, leaving patients with limited treatment options. Fewer than 14% of people diagnosed with pancreatic cancer survive beyond five years.

Cancer affects us all. Many of us have lost family, friends or colleagues to this disease. For Professor Tracy Putoczki and her team at WEHI, their response is to use research and discovery to help create new possibilities for patients. The team is exploring the unique characteristics of pancreatic cancer cells, focusing on the proteins found on their surface. Understanding these proteins could reveal new insights into how pancreatic cancer develops and identify potential opportunities for future treatments.

What this could unlock

Hearts & Minds funding, as nominated by Cooper Investors, has enabled Professor Putoczki’s team to pursue ambitious discovery research that could uncover new approaches to treating pancreatic cancer. This includes building the tools, creating the datasets and bringing together the collaborations needed to translate laboratory findings into real-world impact.

By mapping the surface of pancreatic cancer cells, the researchers aim to identify proteins that could become druggable targets and form the foundation for future therapies. If the team identifies a novel drug target, the next steps will be to demonstrate that targeting it can change the behaviour of the cancer and, if successful, progress towards the drug development pipeline with the aim of developing future treatments for patients.

While this research is still in its early stages, building a deeper understanding of pancreatic cancer cells is an important first step towards uncovering new treatment opportunities. Ultimately, Professor Tracy Putoczki and her team want to move the dial on survivorship and give more people diagnosed with pancreatic cancer the opportunity to live longer, with a better quality of life.

This project is supported by Hearts and Minds Investments, as nominated by Cooper Investors. For further information and updates, visit WEHI.

The challenge 

Pancreatic cancer remains one of the deadliest cancers in Australia. It is the third most common cause of cancer-related death, with an incidence rate of 14 cases per 100,000 people. It is particularly difficult to treat because it is often diagnosed at an advanced stage, leaving patients with limited treatment options. Fewer than 14% of people diagnosed with pancreatic cancer survive beyond five years.

Cancer affects us all. Many of us have lost family, friends or colleagues to this disease. For Professor Tracy Putoczki and her team at WEHI, their response is to use research and discovery to help create new possibilities for patients. The team is exploring the unique characteristics of pancreatic cancer cells, focusing on the proteins found on their surface. Understanding these proteins could reveal new insights into how pancreatic cancer develops and identify potential opportunities for future treatments.

What this could unlock

Hearts & Minds funding, as nominated by Cooper Investors, has enabled Professor Putoczki’s team to pursue ambitious discovery research that could uncover new approaches to treating pancreatic cancer. This includes building the tools, creating the datasets and bringing together the collaborations needed to translate laboratory findings into real-world impact.

By mapping the surface of pancreatic cancer cells, the researchers aim to identify proteins that could become druggable targets and form the foundation for future therapies. If the team identifies a novel drug target, the next steps will be to demonstrate that targeting it can change the behaviour of the cancer and, if successful, progress towards the drug development pipeline with the aim of developing future treatments for patients.

While this research is still in its early stages, building a deeper understanding of pancreatic cancer cells is an important first step towards uncovering new treatment opportunities. Ultimately, Professor Tracy Putoczki and her team want to move the dial on survivorship and give more people diagnosed with pancreatic cancer the opportunity to live longer, with a better quality of life.

This project is supported by Hearts and Minds Investments, as nominated by Cooper Investors. For further information and updates, visit WEHI.

Disclaimer: This material has been prepared by Hearts & Minds, published on July 1, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Picture: A/Prof Melissa Call & Prof Matt CallPicture: A/Prof Melissa Call & Prof Matt CallPicture: A/Prof Melissa Call & Prof Matt CallPicture: A/Prof Melissa Call & Prof Matt Call
July 1, 2026

Next generation CAR T-cell therapy for cancer

The Call Lab at WEHI is pioneering innovative approaches to find this ‘goldilocks zone’, making CAR T-cell therapy safer and more effective.

Read More
Picture: Associate Professor Neale CohenPicture: Associate Professor Neale CohenPicture: Associate Professor Neale CohenPicture: Associate Professor Neale Cohen
July 1, 2026

Revolutionising Diabetes Care

Improving diabetes care has the potential to transform individual health outcomes while strengthening the wellbeing of entire communities.

Read More
HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).HM1 Chief Operating Officer Maggie O’Neill with A/Prof Elizabeth Ng at the Murdoch Children's Research Institute in Melbourne (March 2026).
May 4, 2026

How science turned back the clock of human development to create a miracle blood stem cell

Many thought it could never be done. But three Murdoch Children’s Research Institute scientists recreated embryonic development to crack the blood stem cell code.

Read More
November 15, 2024

Professor Alex Brown in conversation with Professor Jason Kovacic

At the 2024 Sohn Hearts & Minds Conference, we heard from Professor Alex Brown in conversation with Professor Jason Kovacic about Indigenous heart health and genomics.

Read More

A/Professor Tim Sargeant | 2024 Sohn Hearts & Minds Conference

Associate Professor Tim Sargeant has been at SAHMRI (South Australian Health and Medical Research Institute) in Adelaide where he studies the role of lysosomes in Alzheimer’s disease.

Read More
July 1, 2026

Unlocking the mysteries of the human brain

The Sydney Brain Bank is helping researchers uncover the causes of neurodegenerative disease and build a future with better diagnosis, treatment and prevention.

Read More
Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.Bionics Institute researchers A/Prof Sophie Payne and Dr Tomoko Hyakumura.
July 1, 2026

A new approach to Parkinson’s Disease

Exploring nerve stimulation as a potential treatment.

Read More
Dr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds ConferenceDr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds ConferenceDr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds ConferenceDr Eleanor Drummond presenting at the 2025 Sohn Hearts & Minds Conference
July 1, 2026

Revealing what drives PSP

Mapping the biological changes behind progressive supranuclear palsy in the brain.

Read More
Picture: Dr Jennifer SnaithPicture: Dr Jennifer SnaithPicture: Dr Jennifer SnaithPicture: Dr Jennifer Snaith
July 1, 2026

Advancing treatment options for type 1 diabetes

Improving blood glucose and reducing insulin needs.

Read More
Picture: Dr Hamish KingPicture: Dr Hamish KingPicture: Dr Hamish KingPicture: Dr Hamish King
July 1, 2026

Solving the genetic causes of autoimmune diseases

Mapping hundreds of risk markers to better understand how these diseases develop and progress

Read More
July 1, 2026

The Future of Pain Management

Enhancing healthcare professionals' ability to deliver better pain management, now and into the future.

Read More
July 1, 2026

Harnessing the power of stem cell technology

Developing cell therapies for patients with blood diseases

Read More
Picture: Professor Kazuaki NegishiPicture: Professor Kazuaki NegishiPicture: Professor Kazuaki NegishiPicture: Professor Kazuaki Negishi
July 1, 2026

Protecting the heart when every minute matters

Investigating a new treatment to reduce heart damage after heart attacks

Read More
Picture: Associate Professor Orazio VittorioPicture: Associate Professor Orazio VittorioPicture: Associate Professor Orazio VittorioPicture: Associate Professor Orazio Vittorio
July 1, 2026

Targeting the drivers of cancer growth

Exploring how extrachromosomal DNA (ecDNA) drives cancer growth, spread and treatment resistance.

Read More
July 1, 2026

Improving the diagnosis of muscle disorders using advanced genetic testing

Focused on improving the efficiency and accuracy of diagnosing muscle disorders.

Read More